NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Maravai LifeSciences investors who were adversely affected by alleged securities fraud between August 7, 2024 and February 24, 2025. Follow the link below to get more information and be contacted by a member of our team: http ...

NEW YORK, April 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Maravai LifeSciences investors who were adversely affected by alleged securities fraud between August 7, 2024 and February 24, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zl ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 28, 2025 (GLOBE NEWSWIRE) --  The Portnoy Law Firm advises Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ: MRVI) investors of a class action representing investors that bought securities between August 7, 2024 and February 24, 2025, inclusive (the "Class Period"). Acadia Healthcare investors have until May 5, 2025 to file a lead plaintiff motion. Investors are encouraged to ...

公司诉讼事件 - Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) 面临股东集体诉讼 涉及2024年8月7日至2025年2月24日期间购买股票的投资者 [1][3] - 诉讼指控公司在上述期间存在财务报告内控缺陷 具体涉及收入确认不准确 导致2024财年部分交易收入被错误记录 [3] - 公司商誉资产被指控存在高估问题 且管理层关于业务运营和前景的正面陈述被指具有重大误导性 [3] 法律程序细节 - 股东参与诉讼的截止日期为2025年5月5日 需通过指定链接提交损失申报表 [4] - 符合资格的股东注册后将获得案件进展监控服务 无需承担参与诉讼的费用 [4] 律所背景 - Gross Law Firm作为本次诉讼代理方 专注于上市公司证券欺诈类集体诉讼 总部位于纽约 [5][6] - 该律所主要维护因企业虚假陈述或重大信息遗漏导致投资损失的股东权益 [5]

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025, both dates inclusive (the “Class Period”), of the important May 5, 2025 lead plaintiff deadline. SO WHAT: If you purchased Maravai securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fe ...

集体诉讼案件 - 罗森律师事务所提醒在2024年8月7日至2025年2月24日期间购买Maravai Lifesciences Holdings Inc证券的投资者注意2025年5月5日的首席原告截止日期 [1] - 投资者可能有权通过应急费用安排获得补偿而无需支付任何自付费用 [2] - 集体诉讼已经提起 首席原告需在2025年5月5日前向法院提出申请 [3] 律师事务所背景 - 罗森律师事务所在证券集体诉讼领域具有领先地位 2017年证券集体诉讼和解数量排名第一 [4] - 该律所自2013年以来每年排名前四 已为投资者追回数亿美元 2019年单年就为投资者获得4.38亿美元赔偿 [4] - 创始合伙人Laurence Rosen被Law360评为原告律师界泰斗 多名律师获得Lawdragon和Super Lawyers认可 [4] 案件指控内容 - 指控Maravai在集体诉讼期间存在虚假和/或误导性陈述及未披露事项 [5] - 具体包括：财务报告内部控制不足导致2024财年某些交易收入确认不准确 商誉被高估 [5] - 被告对Maravai业务运营和前景的正面陈述因此缺乏合理基础且具有重大误导性 [5] 参与方式 - 投资者可通过指定网址或电话联系Phillip Kim律师参与集体诉讼 [3][6] - 在集体认证前 投资者需自行聘请律师或选择不作为 是否担任首席原告不影响未来潜在赔偿份额 [7] 律所联系方式 - 提供纽约总部地址及电话/传真等联系方式 [8] - 列出LinkedIn Twitter Facebook等社交媒体账号供投资者关注案件进展 [8]

NEW YORK, April 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Maravai LifeSciences investors who were adversely affected by alleged securities fraud between August 7, 2024 and February 24, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zl ...

NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Maravai LifeSciences investors who were adversely affected by alleged securities fraud between August 7, 2024 and February 24, 2025. Follow the link below to get more information and be contacted by a member of our team: http ...

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP notifies investors of the approaching May 5, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired Maravai Lifesciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ:MRVI) securities during the period from August 7, 2024, through February 24, 2025 (“the Class Period”). [LEARN MORE ABOUT THE CLASS ACTION] On February 25, 2025, before the market ope ...

DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Maravai lacked adequate internal controls over financial reporting related to revenue recognition; (2) as a result, Maravai inaccurately recognized revenue on certain transactions during fiscal 2024; (3) its goodwill was overstated; and (4) as a result of the foregoing, defendants' positive statements about Maravai's business, operations, and prospect ...